Article

Stable isotope methods for high-precision proteomics. Drug Discov. Today 10, 353-363

Target Discovery Inc., 4015 Fabian Way, Palo Alto, CA 94303, USA.
Drug Discovery Today (Impact Factor: 5.96). 04/2005; 10(5):353-63. DOI: 10.1016/S1359-6446(05)03381-7
Source: PubMed

ABSTRACT Stable isotope tagging methods provide a useful means of determining the relative expression level of individual proteins between samples in a mass spectrometer with high precision (coefficients of variation less than 10%). Because two or more samples tagged with different numbers of stable isotopes can be mixed before any processing steps, sample-to-sample recovery differences are eliminated. Mass spectrometry also allows post-translational modifications, splice variations and mutations (often unnoticed in immunoassays) to be detected and identified, increasing the clinical relevance of the assay and avoiding the issues of non-specific binding and cross-reactivity observed in immunoassays. Several stable isotope tagging methods are available for use in proteomics research. We discuss the advantages and disadvantages of each technique with respect to biomarker discovery, target validation, efficacy and toxicology screening and clinical diagnostic applications.

Download full-text

Full-text

Available from: Luke V Schneider, Jun 13, 2014
1 Follower
 · 
105 Views
  • Source
    • "As mentioned previously, the TD1 and TD2 buffers are fully compatible with the common protein labeling chemistries (data not provided). We have applied the described immunoaffinity/MS method using isotope-differentiated binding energy shift tags in our laboratory (data not shown) [65]. This intact protein capture approach allows the detection of novel protein isoforms (either sequence variants or posttranslational modifications) that may be lost in other biomarker validation methods such as multireaction monitoring (MRM) [66] or the use of stable isotope standards with antipeptide antibody enrichment (SISCAPA) [67]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Integral membrane proteins play key biological roles in cell signaling, transport, and pathogen invasion. However, quantitative clinical assays for this critical class of proteins remain elusive and are generally limited to serum-soluble extracellular fragments. Furthermore, classic proteomic approaches to membrane protein analysis typically involve proteolytic digestion of the soluble pieces, resulting in separation of intra- and extracellular segments and significant informational loss. In this paper, we describe the development of a new method for the quantitative extraction of intact integral membrane proteins (including GPCRs) from solid metastatic ovarian tumors using pressure cycling technology in combination with a new (ProteoSolve-TD) buffer system. This new extraction buffer is compatible with immunoaffinity methods (e.g., ELISA and immunoaffinity chromatography), as well as conventional proteomic techniques (e.g., 2D gels, western blots). We demonstrate near quantitative recovery of membrane proteins EDG2, EDG4, FASLG, KDR, and LAMP-3 by western blots. We have also adapted commercial ELISAs for serum-soluble membrane protein fragments (e.g., sVEGFR2) to measure the tissue titers of their transmembrane progenitors. Finally, we demonstrate the compatibility of the new buffers with immunoaffinity enrichment/mass spectrometric characterization of tissue proteins.
    07/2012; 2012:838630. DOI:10.1155/2012/838630
  • Source
    • "Following experimental manipulation, cell culture extracts or conditioned media are combined, processed and the relative abundance of ''heavy'' to ''light'' peptide may be assessed to identify differentially expressed proteins. Other recent variants of MCL include iTRAQ [48] and isotope-differentiated binding energy shift tags (IDBEST) [49]. With iTRAQ up to four different protein samples may be coded by reporter-specific reactive groups that covalently bind to lysine side chains and N-termini. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the past decade, proteomics has undergone a rapid development and radiation, diversifying across the biochemical landscape. While no single technique yet delivers complete proteomic coverage, application-specific adaptations afford significant opportunity for discovery and the development of predictive capacity (e.g. surrogate biomarker and clinical diagnostics). Targeted proteomic approaches, protein profiling strategies using affinity capture mass spectrometry and solution array represent realistic opportunities to deliver predictive capacity. The aim of this review is to provide an overview of proteomic technologies and how the outcomes delivered by such platforms may be translated into applications of predictive utility in clinical and basic science. In particular, recent applications in protein/peptide profiling (solid-phase affinity capture mass spectrometry and the targeted approach of antibody arrays) and the opportunities they afford researchers within the discipline of reproductive biology to develop new diagnostic and prognostic tests and surrogate biomarkers to improve the delivery of women's health care are considered.
    Placenta 05/2006; 27 Suppl A:S76-86. DOI:10.1016/j.placenta.2005.11.003 · 3.29 Impact Factor
  • Source
    • "Stable Isotope Labeling by Amino Acid in Cell Culture) (Ong et al. 2002), GIST (Global Internal Standard Technology) (Chakraborty and Regnier 2002), I-CAT (Isotope-Coded Affinity Tags) (Gygi et al. 1999), and iTRAQ (Isobaric Tagging for Relative and Absolute Protein Quantitation) (Ross et al. 2004; Schneider and Hall 2005 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genomic and proteomic based global gene expression profiling has altered the landscape of biological research in the past few years. Its potential impact on cell culture bioprocessing has only begun to emanate, partly due to the lack of genomic sequence information for the most widely used industrial cells, Chinese hamster ovary (CHO) cells. Transcriptome and proteome profiling work for species lacking extensive genomic resources must rely on information for other related species or on data obtained from expressed sequence tag (EST) sequencing projects, for which burgeoning efforts have only recently begun. This article discusses the aspects of EST sequencing in those industrially important, genomic resources-poor cell lines, articulates some of the unique features in employing microarray in the study of cultured cells, and highlights the infrastructural needs in establishing a platform for genomics based cell culture research. Recent experience has revealed that generally, most changes in culture conditions only elicit a moderate level of alteration in gene expression. Nevertheless, by broadening the conventional scope of microarray analysis to consider estimated levels of transcript abundance, much physiological insight can be gained. Examples of the application of microarray in cell culture are discussed, and the utility of pattern identification and process diagnosis are highlighted. As genomic resources continue to expand, the power of genomic tools in cell culture processing research will be amply evident. The key to harnessing the immense benefit of these genomic resources resides in the development of physiological understanding from their application.
    Cytotechnology 04/2006; 50(1-3):121-40. DOI:10.1007/s10616-006-9004-9 · 1.45 Impact Factor
Show more